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resin was washed with 5% DIPEA in DMF (10 mL) for 2 x 30 min in order to neutralize the remaining TFA.
Fmoc-Leu-OH and Boc-Ala-OH were coupled as described previously, using (371 mg) of of Fmoc-Ala-OH.
The resin was washed 3 times with DMF (10 mL), 3 times with CH 2 Cl 2 (10 mL) and dried.
The peptide was cleaved from the dried resin using the following mixture: TFA/TIPS/H 2 O (95/2.5/2.5) for 2 hours. The cleavage solution (<10 mL) was precipitated in prechilled diethyl ether (30 mL), centrifuged, and the supernatant was removed. Peptides were dissolved in H 2 O followed by the purification by RP-HPLC on a semipreparative column (C18 column, Gemini, 5 µm, 10 ×250 mm; Phenomenex) at a flow rate of 3.0 mL/min: solvent A, 0.1% TFA in H2O; solvent B, 0.1% TFA in CH 3 CN. Gradient: 5% to 70% in 20 min. The fractions containing the pure product were collected and lyophilized. 
double stranded oligonucleotides-based linker synthesis
5Am5 CCC GCT GAA TTC GCT AGT CCC 3' 3' GGG CGA CTT AAG CGA TCA GGG 5Am5'
Oligonucleotides were synthesized using a PerSeptive Biosystems Expedite 8909 DNA synthesizer according to manufacturer's protocols on 1 µmol scale (based on resin loading).
All reagents for DNA synthesis were purchased from Glen Research, including standard DNA bases and the 5'-Amino-Modifier 5 (10-1905-90) .
After the synthesis of the oligonucleotides, Fmoc-G3-OH was coupled to the resin using the standard Fmoc-SPPS protocol: Fmoc-G3-OH (20.6 mg, 50 µmol, 50 equiv.), HATU (18.2 mg, 48 µmol, 48 equiv.) and DIPEA (17.5 µL, 0.1 mmol, 100 equiv.) were dissolved in 1 mL of DMF. After premixing for 1 min, the pre-activated solution was added to the resin and agitated for 4 h. The same protocol was followed to attach Fmoc-AL-OH (21.2 mg, 50 mmol, 50 equiv.)
Oligodeoxynucleotides were purified by RP-HPLC on an Agilent 1200 system using a C18 stationary phase (Eclipse-XD-B C18, 5 µM, 9.4 x 200 mm) and an acetonitrile/ 100 mM triethylammonium acetate gradient. Oligonucleotide concentrations were quantitated using a Nanodrop ND1000 spectrophotometer. Oligonucleotides were characterized by LC/ESI-MS.
Reverse-phase separation was performed on a Waters Acquity ultra-performance LC (UPLC) quadrupole TOF Premier instrument using a UPLC BEH C18 column (1.7 µM, 2.1 x 50 mm) S4 stationary phase and 6 mM aqueous triethylammonium bicarbonate/MeOH mobile phase. The fractions with the desired molecular weight were combined and lyophilized.
The two oligos were dissolved in annealing buffer (10 mM Tris, pH 7.5, 50 mM NaCl and 1 mM EDTA) at a final concentration of 200 µM each. Equal amounts of each oligo were combined and heated up to 75 ºC for 5 min and then was allowed to cool to rt over 60 min.
The resulting product was dialyzed (MW cut off 10 kDa) against ammonium carbonate buffer (10 mM), lyophilized and used directly for the ligation reactions. 
Fluorescent probes
The GGG-probe was synthesized using Rink Amide resin (500 mg, 0.26 mmol, loading: 0.52 mmol/g). Commercially available Boc-G3-OH (Chem-Impex) was used to accelerate the synthesis.
Fmoc-(Mtt)Lys-OH was coupled to the resin using the following conditions: Fmoc-(Mtt)Lys-OH (483 mg, 0.78 mmol, 3.0 equiv.) HATU (277 mg, 0.73 mmol, 2.8 equiv.) and DIPEA (272 µL, 1.56 mmol, 6.0 equiv.) were dissolved in DMF (6 mL). After premixing for 1 min, the preactivated solution was added to the resin and agitated for 2 h. The Fmoc protecting group was removed by treating the resin with 20% piperidine in DMF (2 x 10 mL) for 10 min each followed by washes with DMF (3 x 10mL).
Boc-G 3 -OH was coupled to the resin by dissolving, in DMF (8.0 mL), Boc-G 3 -OH (226 mg, 0.78 mmol, 3.0 equiv.), HATU (277 mg, 0.73 mmol, 2.8 equiv.) and DIPEA (272 µL, 1.56 mmol, 6.0 equiv.). After premixing for 1 min, the pre-activated solution was added to the resin and agitated for 2 h and the resin was then intensively washed with DMF (3 x 10mL).
Removal of the Mtt protecting group was performed by treating the resin with 1% TFA in CH 2 Cl 2 (10 mL) for 2 X 30 min and then for another hour. The solvent was removed and the resin was washed with 5% DIPEA in DMF (10 mL) for 2 X 30 min in order to neutralize the remaining TFA 5,6-Carboxyfluorescein (194 mg, 0.52 mmol, 2 equiv.) HATU (178 mg, 0.47 mmol, 1.8 equiv.) and DIPEA (181 µL, 1.04 mmol, 4.0 equiv.). After premixing for 1 min, the preactivated solution was added to the resin and agitated for 2 h and the resin was then extensively washed with DMF (3 x 10mL).
The peptide was cleaved from the dried resin using the following mixture: TFA/TIPS/H 2 O (95/2.5/2.5) for 2 hours. The cleavage solution (<10 mL) was precipitated in prechilled S6 diethylether (30 mL), centrifuged and the supernatant was removed. Peptides were dissolved in H 2 O followed by the purification by RP-HPLC on a semipreparative column (C18 column, Gemini, 5 µm, 10 ×250 mm; Phenomenex) at a flow rate of 3.0 mL/min: solvent A, 0.1% TFA Fmoc-(Trt)Cys-OH was coupled to the resin using the following conditions: Fmoc-(Trt)Cys-OH (457 mg, 0.78 mmol, 3.0 equiv.) HATU (277 mg, 0.73 mmol, 2.8 equiv.), N,Ndiisopropylethylamine (DIPEA) (272 µL, 1.56 mmol, 6.0 equiv.) were dissolved in DMF (6.0 mL). After premixing for 1 min, the pre-activated solution was added to the resin and agitated for 2 h. The Fmoc protecting group was removed by treating the resin with 20% piperidine in DMF (2 x 10 mL) for 10 min each followed by washes with DMF (3 x 10mL). A similar protocol was followed for the coupling of Fmoc-Leu-OH and Fmoc-Ala-OH, using 275 mg of Fmoc-Leu-OH and 243 mg of Fmoc-Ala-OH The resin was washed 3 times with DMF (10 mL), 3 times with CH 2 Cl 2 (10 mL) and dried.
The peptide was cleaved from the dried resin using the following mixture: TFA/TIPS/H 2 O (95/2.5/2.5) for 2 hours. The cleavage solution (<10 mL) was precipitated in prechilled diethylether (30 mL), centrifuged and the supernatant was removed. The peptide was dissolved in H2O and lyophilized without purification.
Alexa-647 Maleimide (400 µL, ~2 mM) was added to a pH 7.8 solution of the ALCG peptide (200 µL, 4 mM) in water and agitated for 4 hours at room temperature. 1 mL was added to the resulting mixture followed by purification by RP-HPLC on a semipreparative column (C18 column, Gemini, 5 µm, 10 x 250 mm; Phenomenex) at a flow rate of 3.0 mL/min: solvent A, 0.1% TFA in H2O; solvent B, 0.1% TFA in CH 3 CN. Gradient: 5% to 90% in 20 min. Fractions containing pure product were collected and lyophilized.
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Isolation and purification of butelase 1
300 g of pods of C. ternatea were homogenized with 500 mL of extraction buffer (20 mM sodium phosphate, 1 mM EDTA, 1 mM PMSF and 5 mM β-mercaptoethanol (β-ME), pH 6.0).
The extraction was conducted at 4 °C to minimize protein degradation. The homogenate was centrifuged and filtered to remove plant debris. Ammonium sulfate was added to the supernatant to reach 20% saturation. The precipitated proteins were discarded, and ammonium sulfate was continually added to the supernatant to reach 85% saturation. After centrifugation, the supernatant was discarded, and the precipitated proteins were re-dissolved in 300 mL of extraction buffer.
The dissolved sample was dialyzed overnight against 6 l of extraction buffer using a 10-kDa cutoff dialysis tubing. The dialyzed sample was centrifuged and filtered to give the crude extract of C. ternatea. This crude extract was applied to a flash column containing 100 mL slurry of Q-Sepharose Fast Flow anion-exchange resin (GE Healthcare). The column was washed with 800 mL of buffer A (20 mM phosphate buffer, 1 mM EDTA and 5 mM β-ME, pH 6.0) and eluted with 400 mL of buffer B (20 mM sodium phosphate, 1 mM EDTA, 5 mM β-ME and 200 mM KCl, pH 6.0). The eluent was concentrated to a final volume of 3 mL using 10-kDa cutoff centrifugal filter units (Amicon Ultra, Millipore).
The concentrated sample was subjected to size exclusion chromatography using a BioSuite HPLC column (300 mm × 21.5 mm, Waters). Fractions with peptide cyclase activity were pooled and further purified by anion-exchange chromatography using an analytical PolyWAX HPLC column (200 mm × 4.6 mm, PolyLC) with a linear gradient of 0-500 mM sodium chloride in 60 min. The enzyme purity was analyzed by SDS-PAGE and silver staining. Approximately 0.4 mg butelase 1 was obtained from 300 g of plant materials. Using a double stranded oligonucleotide-based linker VHH7 (75 µM) was incubated at 4 ºC with the oligonucleotide linker (500 µM) and sortase A (2.0 µM) overnight. The reaction was assumed to be complete and the His-tagged sortase was removed by depletion on Ni-NTA agarose beads. The remaining ds-oligo was removed by dialysis using a cut off of (20 kDa) for 2 days with regular buffer exchange.
C-to-C fusion protein using the two different types of linkers
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To the ligated product (250 µM) VHH-Enh (25 µM) and butelase 1 (1.0 µM) were added and incubated at 37 ºC for 6 hours with agitation. The solution was dialyzed using a membrane with a 30 kDa cut off or purified by FPLC. The desired product as observed by SDS-PAGE was obtained in an overall yield of ~25%.
For SDS-PAGE visualization, in order to avoid dissociation of the double stranded oligonucleotide linker, the construct was heated up to only 50 ºC for 10 minutes. Fortunately, we were able to obtain gels of good qualities.
Cleavage of the linker using EcoRI
The construct was concentrated using a spin filter system to a final concentration of ~30 µM estimated by nanodrop at 280 nm. 36 µL of the solution was diluted with the 4 µL of 10X
NEBuffer to a final volume of 40 µL and finally EcoRI (purchased from NEB 2 µL, 40 units, potential to digest 40 µg of oligonucleotide in 1 h, in this case EcoRI was in excess) was added. The resulting mixture was agitated for 1.5 h at 37 ºC, then concentrated again and was analyzed by SDS-PAGE. IgG1 (10 µM) was incubated with the GGG-FAM (500 µM), the AL-Alexa (500 µM), sortase A (2 µM) and butelase 1 (0.8 µM). The ligation mixture was incubated first at 4 ºC overnight followed by incubation at 37 ºC for 4 hours. Simple centrifugation-based size exclusion was sufficient to remove unincorporated dyes to obtain pure dually modified antibody. The different labeled chain could be visualized by SDS-PAGE using the different excitation channels on a Bio-Rad ChemiDoc MP TM Imaging system.
